Supreme Court Rebukes RBI for Remaining a Bystander as YES Bank Operated Clandestinely || Supreme Court: Lower Fresh Bids Alone Cannot Justify Cancellation of an Auction || Supreme Court Directs Delhi Police to Produce Section 163 BNSS Orders and Preserve CCTV Footage || Supreme Court Affirms Menstrual Hygiene as a Fundamental Right, Warns States of Contempt || Supreme Court Flags AI-Generated Fake Judgments Submitted in a Party’s Case Compilation || Karnataka High Court: Vijay Mallya’s Flamboyant Lifestyle Hinders Settlement of Bank Claims || Delhi High Court: Women can be Booked for Gang Rape without Physically Committing it || Delhi High Court: Litigants Must Track Their Cases and Cannot Blame Lawyers for Their Own Inaction || Allahabad High Court: Contract Workers Must Prove Work Parity With Regular Staff for Equal Pay || Allahabad High Court Directs UP Trial Courts to Decide Maintenance Execution Cases Within Six Months

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :